Nasal nitric oxide testing for better care in primary ciliary dyskinesia
Official title: Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
Run by Arkansas Children's Hospital Research Institute · NCT05287022 · Data updated 2026-11-12
This study is trying to see if measuring nitric oxide in the nose can help doctors diagnose primary ciliary dyskinesia more accurately for patients at Arkansas Children's Hospital.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 2 Years to 99 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Arkansas Children's Hospital Research Institute Academic / other |
| Locations | 1 site (Little Rock, Arkansas) |
| Status | Recruiting |
| Started | June 14, 2021 |
| Main results expected | June 2030 |
| Study ends | June 2030 |
| Registry record updated | January 30, 2025 |
| Trial ID | NCT05287022 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with primary ciliary dyskinesia, those with abnormal diagnostic results, or individuals with unexplained bronchiectasis.
✕Probably not a fit
Patients who do not meet the inclusion criteria or have conditions unrelated to primary ciliary dyskinesia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to enhance the understanding of primary ciliary dyskinesia (PCD) by measuring nitric oxide levels in the nasal passages and correlating these results with existing diagnostic tests. Participants referred for nasal nitric oxide testing will undergo the procedure after providing informed consent. The study will collect data from electronic medical records to refine diagnostic testing for PCD at Arkansas Children's Hospital, involving collaboration with various medical specialties. The ultimate goal is to improve the accuracy of PCD diagnosis and potentially lead to the approval of nasal nitric oxide testing as a diagnostic tool.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic accuracy for patients with primary ciliary dyskinesia.
How similar studies have gone: While this approach is novel in the context of PCD, similar studies using nitric oxide testing in other respiratory conditions have shown promise.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals who are diagnosed with Primary Ciliary Dyskinesia OR * Individuals with abnormal PCD diagnostics (abnormal ciliary biopsy or PCD genetics) OR * Individuals with unexplained bronchiectasis OR * Individuals undergoing PCD diagnostic testing (ciliary biopsy, PCD genetic testing) or concern based on clinical symptoms (at least two of the following): * Neonatal respiratory distress * Organ laterality defects * Year-round cough starting in first year of life or bronchiectasis on chest CT * Year-round nasal congestion starting in first year of life or pansinusitis * Multiple ear infections in the first two years of life with sequelae (e.g. ear tubes, chronic effusion, abnormal audiological exam) * History of recurrent pneumonias (at least 2 in one year or more than 3 at any time) * Ability to provide consent for participation in study by the participants or guardian * Ability to perform the test * Age \>= 2 years of age Exclusion Criteria: * Individuals who are unable to understand the requirements of the study. * Individuals (or guardians) who are unwilling to provide consent. * Individuals who are unable to complete the testing * Recent history of sinus surgery (within four weeks) or bloody nose (within one week) of testing (they can be included at a later date) * Patients who are currently being treated (within one week) with antibiotics for sinusitis or respiratory symptoms (they can be included at a later date) * Age \<2 years of age
Where it's running
-
Arkansas Children's Hospital
Little Rock, Arkansas, United States Recruiting
Study contacts
- Study coordinator: Zena Ghazala, MD
- Email: zbghazala@uams.edu
- Phone: 5013641006
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bronchial hyperresponsiveness in children with primary ciliary dyskinesia
This will see if children with primary ciliary dyskinesia have sensitive airways (bronchial hyperresponsiveness) by using a methacholine breathing challenge and related tests.
-
PALMIRE cohort: phenotyping inflammatory lung diseases to enable personalized care
This project will collect clinical, imaging, and biological data from adults with asthma, COPD, bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, or interstitial lung disease to try to identify disease subtypes and markers that could guide more personalized care.
-
Thermal spa treatment to improve symptoms of primary ciliary dyskinesia
We will try a 3-week thermal spa treatment in adults with primary ciliary dyskinesia to see if it improves ear, nose, and throat symptoms, lowers infection and antibiotic rates, and helps hearing and lung function.
-
Glycine and magnesium plus thiamine for primary ciliary dyskinesia
This trial will test whether daily oral glycine and magnesium with thiamine, alone or combined, can help people aged 5 and older with primary ciliary dyskinesia clear mucus and breathe better.
-
Observational study on Primary Ciliary Dyskinesia
This study looks at people with Primary Ciliary Dyskinesia to see what factors might affect how severe their condition is and to help improve their care.
-
Using nasal nitric oxide testing to improve diagnosis of primary ciliary dyskinesia
This study is testing if a simple nasal test can help doctors diagnose primary ciliary dyskinesia in people aged 2 and older who show symptoms of the condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.